FLT3 Inhibitors in AML

被引：0
|
作者：
Stone, R. M. [1 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Adult Leukemia Program, Boston, MA 02115 USA
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] FLT3 Inhibitors in Mutant FLT3 AML
    Stone, Richard M.
    Garcia, Jacqueline
    ANNALS OF HEMATOLOGY, 2017, 96 : S36 - S37
  • [2] FLT3 Inhibitors in AML
    Perl, Alexander
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S1 - S2
  • [3] FLT3 Inhibitors in AML
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S101 - S102
  • [4] Use of FLT3 Inhibitors in AML
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S92 - S94
  • [5] FLT3 Inhibitors in AML: Are We There Yet?
    Akshay Sudhindra
    Catherine Choy Smith
    Current Hematologic Malignancy Reports, 2014, 9 : 174 - 185
  • [6] FLT3 Inhibitors in AML: Are We There Yet?
    Sudhindra, Akshay
    Smith, Catherine Choy
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (02) : 174 - 185
  • [7] A Review of FLT3 Kinase Inhibitors in AML
    Negotei, Cristina
    Colita, Andrei
    Mitu, Iuliana
    Lupu, Anca Roxana
    Lapadat, Mihai-Emilian
    Popovici, Constanta Elena
    Crainicu, Madalina
    Stanca, Oana
    Berbec, Nicoleta Mariana
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [8] Novel FLT3 Inhibitors and Targeted Therapies in AML
    Levis, M.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 35 - 37
  • [9] Novel FLT3 Inhibitors and Targeted Therapies in AML
    Levis, M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S35 - S37
  • [10] Can FLT3 inhibitors overcome resistance in AML?
    Tam, Winnie F.
    Gilliland, Gary
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (01) : 13 - 20
12345